The frequencies of CD1c+CD14+ DC3s in PB of patients with RA correlating with disease activity, combined with the high levels of pro-inflammatory CD14+ DC3s in SF, suggests that proinflammatory cytokines driving IA may also drive the development of CD14+ DC3s. This evidence concerns the gene CD1C and rheumatoid arthritis.